1 Mucosal Inflammation Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada; 2 Department of Physiology, Ponce School of Medicine, Ponce, Puerto Rico 00732-7004; and 3 Institute of Parasitology, McGill University, Montreal, Quebec H9X 3V9, Canada
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Epithelial secretion may play an important role in reducing bacterial colonization and translocation in intestine. If so, secretory dysfunction could result in increased susceptibility to infection and inflammation. We investigated whether long-term colonic secretory dysfunction occurs after a bout of colitis and if this is accompanied by an increase in bacterial colonization and translocation. Rats were studied 6 wk after induction of colitis with trinitrobenzene sulfonic acid when inflammation had completely resolved, and epithelial permeability was normal. Intestinal loops were stimulated with either Clostridium difficile toxin A or a phosphodiesterase inhibitor. In vitro, colonic tissue from previously sensitized rats was exposed to antigen (ovalbumin). Secretory responses to all three stimuli were suppressed in rats that had previously had colitis. These rats exhibited increased (16-fold) numbers of colonic aerobic bacteria and increased (>3-fold) bacterial translocation, similar to results in rats studied after resolution of enteritis. Postcolitis bacterial translocation was prevented by daily treatment with an inhibitor of inducible nitric oxide synthase. This study demonstrates that intestinal inflammation results in prolonged impairment of colonic epithelial secretion, which may contribute to increases in bacterial load and bacterial translocation. Epithelial dysfunction of this type could underlie an increased propensity for further bouts of inflammation, a hallmark of diseases such as inflammatory bowel disease.
inflammatory bowel disease; colonic inflammation; permeability; irritable bowel syndrome
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
THE INTESTINAL
EPITHELIUM plays an essential role in host defense by preventing
the entry of bacteria and other potentially harmful substances into the
lamina propria. In addition to diluting luminal toxins, the secretion
of water and mucus by the epithelium may assist in preventing the
adherence and invasion of microbes. Impairment of epithelial barrier
function and/or secretion could therefore result in an increased
susceptibility to infection and inflammation. Inflammation of the
gastrointestinal mucosa in various species is associated with the
release of a number of soluble mediators that have the capacity to
influence intestinal epithelial function (49, 53, 54). For
example, interleukin (IL)-4 and prostaglandin D2 have been
shown to decrease epithelial chloride secretion, and IL-4, IL-13, and
interferon- have been shown to diminish epithelial barrier function
(9, 25, 30, 56). It has previously been demonstrated, in
various species, that inflammation of the colon is accompanied by an
acute reduction in epithelial responsiveness to secretagogues (3,
15, 22, 29). We have further shown that, in the rat, such
changes are long lasting, at least when assessed in vitro. Thus the
colonic epithelium was found to be hyporesponsive to electrical field stimulation, IBMX, and carbachol for up to 12 wk after induction of
colitis (1). Indeed, we have recently observed that the hyporesponsiveness to electrical field stimulation is still apparent in
rats 27 wk after a bout of colitis (unpublished observations). This epithelial dysfunction was attributed, at least in part, to the
release of nitric oxide (NO) from the inducible isoform of NO synthase
(iNOS) (1).
Altered colonic secretion following a bout of inflammation could be attributable to a number of factors, including changes in the enterocyte itself or to the other cells that participate in the secretory response to various agonists (e.g., nerves, mast cells). For example, since enteric nerves play an important role in the secretory response to some agonists (7, 51), it is possible that alterations in innervation of the colon or in neurotransmitter release would result in epithelial hyposecretion. Indeed, it is noteworthy that significant decreases in the release of norepinephrine from myenteric nerves have been observed in rats following a bout of colitis (20). Interestingly, these changes were observed in parts of the intestine that were remote to the site of inflammation (20). Diminished expression of binding sites for substance P has been documented in experimental colitis (12) and could contribute to the hyposecretion to agonists that induce secretion through the release of this neuropeptide. In the previous in vitro studies, we observed that the colonic secretory response was substantially diminished with three distinct agonists, suggesting that changes at the level of the enterocyte most likely accounted for the observed hyporesponsiveness (1).
In the present study, we have investigated the possibility that colonic epithelial secretory dysfunction occurs in vivo and that it persists for many weeks after resolution of a bout of colonic inflammation. We also tested the hypothesis that small intestinal inflammation could produce prolonged alterations in colonic epithelial secretion. We then examined whether the functional consequences of altered secretory function following a bout of colitis or enteritis might include an increase in bacterial colonization of the colon and bacterial translocation across the epithelium, as well as whether or not any such changes could be reversed by an inhibitor of iNOS. Finally, we examined the possibility that a bout of colitis leads to prolonged changes in epithelial proliferation, which could contribute to alterations in secretory and barrier function.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Animals. Male rats of the Wistar, Hooded-Lister, and Sprague-Dawley strains weighing 175-200 g were obtained from Charles River Breeding Farms (Montreal, PQ, Canada). The rats were fed standard chow and water ad libitum. All experiments described below were approved by the Animal Care Committee of the University of Calgary and were performed in accordance with the guidelines of the Canadian Council on Animal Care.
Induction of colonic inflammation. Colitis was induced in Wistar rats as previously described (1, 35). Briefly, a plastic catheter inserted rectally into the colon ~8 cm proximal to the anus was used to instill 30 mg of 2,4,6-trinitrobenzene sulfonic acid (TNBS) dissolved in 0.5 ml of 50% ethanol (vol/vol). A group of age-matched rats, which were left untreated during the course of the study, served as controls. In all experiments, the minimum sample size per group was five.
Colonic fluid secretion was measured 6 wk after TNBS administration and in controls. In separate groups of rats, permeability of the gastrointestinal tract to 51Cr-EDTA was assessed (72 h and 6 wk after intracolonic administration of TNBS or of the 50% ethanol vehicle) and in age-matched, untreated rats, after which samples of colonic tissue were fixed in neutral buffered formalin for histological evaluation. The measurement of permeability to 51Cr-EDTA involved placing rats in individual metabolic cages and collecting urine over a period of 12 h. The rats (n = 6 per group) were given 100 µCi of 51Cr-EDTA (33 Ci/mmol) orally, after which the collection of urine was initiated. The urine samples were then counted in a gamma spectrometer, and the fractional excretion of the 51Cr-EDTA was calculated. The appearance of 51Cr-EDTA in the urine is a measure of total gastrointestinal tract permeability. To determine the extent to which colonic inflammation had resolved 6 wk after intracolonic administration of TNBS or the 50% ethanol vehicle, colonic tissue was excised for measurement of myeloperoxidase activity (MPO) and prostaglandin E2 synthesis (3).Induction of small intestinal inflammation. Sprague-Dawley rats were infected with ~3,000 stage-III Nippostrongylus brasiliensis larvae, as previously described (2). A group of age-matched rats served as controls. In this model, infection of the small intestine (primarily jejunum) occurs 60-120 h after the administration of the larvae, and the infection and the associated small intestinal inflammation is typically cleared by 18-21 days after infection (18, 36, 37). Tissue for histological analysis was taken from the small intestine and colon 52 days after administration of the larvae. A separate group of rats was used for measurement of colonic fluid secretion (see In vivo colonic fluid secretion).
Samples of the small intestine and colon of naïve rats and rats infected with N. brasiliensis 52 days earlier were fixed in Carnoy's solution and processed using routine histological techniques. Sections (7 µm) were mounted on glass slides and stained with hematoxylin and eosin. Coded sections were then assessed for degree of inflammation by an observer who was unaware of the treatments the rats had received.In vivo colonic fluid secretion. Rats were fasted for 24 h and anesthetized with 20% urethane (6 ml/kg), and a laparotomy was performed. Colonic loops (~5 cm) were formed using suture to tie off each end of the distal colon (i.e., the area of previous exposure to TNBS). Care was taken not to disrupt the blood and nerve supplies to the gut. A cannula was inserted into one of the ends of each loop. Clostridium difficile-derived toxin A (10 µg) dissolved in 2 ml of Tyrode's buffer (in mM: 133 NaCl, 4.7 KCl, 1.84 MgSO4, and 20 NaHCO3; pH 7.4) was injected into the colonic loops. In control rats, loops were injected with Tyrode's buffer alone. In other experiments, 2 ml of Tyrode's buffer containing the phosphodiesterase inhibitor IBMX (300 µM) or vehicle were injected instead of toxin A. IBMX was used as another agonist because we found that the epithelium of previously inflamed colon is hyporesponsive to this secretagogue in vitro (1). After 3 h, the loops were carefully excised and the volume of fluid recovered from the loop was recorded. Any changes in the volume of fluid during this period would reflect the difference between secretion and absorption. However, it has been well established that accumulation of fluid in the colon following administration of C. difficile toxin A or IBMX is due to active secretion, with little effect of these agents on absorption (6, 33, 34). Thus, in the present study, we have used the volume of fluid recovered from the colonic loops as an index of secretion. The dry weight of the tissue was determined after desiccation at 60°C for 24 h. Changes in fluid accumulation after administration of C. difficile toxin A could also be attributable to epithelial damage caused by this agent. To test this hypothesis, we used leakage of lactate dehydrogenase into the lumen as an index of cellular disruption. A spectrophotometric assay for lactate dehydrogenase was performed on samples of the luminal fluid from vehicle- and toxin A-treated rats according to a previously described protocol (5).
Role of iNOS. To determine the contribution of iNOS activity to any changes in colonic fluid secretion induced by a prior bout of colitis, rats were treated with NG-iminoethyl- L-lysine (L-NIL; 3 mg/kg ip) or vehicle (saline) 10 min before measurement of colonic fluid secretion. This dose of L-NIL was chosen because it has previously been shown to reverse an endotoxin-induced decrease in blood pressure but had no effect on the blood pressure of normal rats (44).
Effects of TTX. To determine the role of nerves in the hyporesponsiveness observed in rats 6 wk after a bout of colitis, experiments were performed as described in In vivo colonic fluid secretion in which IBMX was used as a secretagogue, but in one-half the rats, (n = 6/group) TTX (10 µM) was added to the fluid that was injected into the colonic loop. This concentration of TTX exceeds that previously shown to significantly inhibit colonic secretion induced by C. difficile toxin A (7).
Mucus secretion. Rats (n = 5-9 per group) that had been fasted for 24 h were given [3H]glucosamine (20 µCi) intraperitoneally to quantify mucus secretion (4). To examine basal mucus secretion, the rats were killed 3 h after injection of the labeled glucosamine. The colon was excised, and the fecal contents were removed before gentle scraping of the luminal surface with a glass slide. These samples were subsequently processed for quantification of the labeled glycoproteins (see below). To examine stimulated mucus secretion, rats were anesthetized with pentobarbital sodium (65 mg/kg ip) 3 h after injection of the labeled glucosamine. Colonic loops (~2 cm long) were formed using suture to tie off each end, and a cannula was inserted into one end of the loop. Previous studies have established that the creation of the loop per se does not induce mucus secretion or cause goblet cell depletion (8). Carbachol (300 µl of a 10 µM solution) was instilled into the colonic loop and left in place for 30 min. At the end of this period, the luminal surface of the loop was gently scraped with a glass slide, as described above. The samples collected in both sets of experiments (basal and carbachol-stimulated) were placed in 5 ml of PBS and were then vortex mixed. After centrifugation at 1,000 g for 10 min, the supernatant was mixed with an equal volume of 10% trichloroacetic acid-1% phosphotungstic acid for 30 min at 4°C to precipitate the glycoproteins. Following centrifugation (2,000 g; 10 min), each pellet was mixed with 4 ml of scintillation cocktail (Ecolite; ICN Biomedicals, Irvine, CA) and counted in a liquid scintillation counter. The amount of radiolabeled glycoprotein secreted was then calculated as counts per milligram of protein per centimeter of colon.
Antigen-induced colonic secretion in vitro.
In experiments examining colonic epithelial responses to antigen,
Hooded-Lister rats were sensitized by intraperitoneal injection of a
1.0-ml solution containing 10 µg of ovalbumin and 1.0 mg of aluminum
hydroxide adjuvant, prepared as previously described (39).
Adjuvant alone was injected in control animals. Two days later,
sensitized and nonsensitized control rats were divided into two groups.
Colitis was induced in one group of sensitized and one group of control
rats by intracolonic administration of TNBS, as described in
Induction of colonic inflammation, and the remaining rats
were left without any further treatment. Following a 6-wk time period
to allow for the colonic inflammation to resolve, blood was taken from
each rat for measurement of ovalbumin-specific reaginic antibody titers
by the passive cutaneous anaphylaxis (PCA) reaction (38).
Rats were considered sensitized if the serum diluted to 1:32 caused a
positive PCA reaction.
Bacterial translocation and colonic bacterial levels. Six weeks after administration of TNBS or vehicle (0.5 ml of 50% ethanol) or 52 days after infection with N. brasiliensis, rats were killed by cervical dislocation (appropriate controls were killed at the same time). The mesenteric lymph node complex and spleen were removed from each rat using sterile technique, as previously described (24). Each tissue was then weighed and homogenized in 5 ml of sterile PBS. Two serial 10-fold dilutions were made of each sample, and 0.1-ml aliquots of each undiluted and diluted sample were plated onto MacConkey and blood agar plates. Following incubation at 37°C for 48 h, bacterial counts were performed. Any mesenteric lymph node or splenic tissue having >20 colony forming units (CFU)/g tissue was classified as positive for translocation of bacteria.
To examine total colonic aerobic bacterial levels (luminal plus adherent and invasive), a segment of colon including luminal contents was placed in 5 ml of sterile PBS. To examine the number of bacteria adherent to or invading the colonic tissue, a second tissue sample (excluding the luminal contents) was placed in 5 ml of PBS and vortexed vigorously for 5 s (24). These samples were then transferred to tubes containing sterile PBS and vortexed again. This was repeated a total of four times. Finally, both tissue samples (for total and for adherent/invasive bacteria) were weighed, homogenized, and diluted before plating of 0.1 ml of each dilution on MacConkey and blood agar plates. Once again, the number of CFU per gram of tissue was recorded for both naïve and TNBS-treated animals. To examine total colonic anaerobic bacterial levels (luminal plus adherent and invasive), a segment of colon including luminal contents was placed in 5 ml of sterile, prereduced brain-heart infusion broth. Following homogenization, the samples were transferred into an anaerobic chamber and diluted in prereduced brain-heart infusion broth before plating of 0.1 ml of each dilution onto blood agar plates. The plates were incubated in anaerobic conditions at 37°C for 72 h, after which bacterial counts were performed as above. To examine the contribution of iNOS-derived NO to bacterial colonization and translocation after a bout of colitis, rats treated 5 wk earlier with TNBS (n = 12) were treated twice daily with L-NIL (3 mg/kg ip) for 7 days. A second group of rats (n = 12) was treated with vehicle (saline) instead of L-NIL.Colonic epithelial proliferation. The detection of proliferating cells in the colonic epithelium was compared in groups of rats treated intracolonically with either TNBS/ethanol or ethanol alone or in rats left untreated. Six weeks later, the rats were given bromodeoxyuridine (BrdU; 150 mg/kg ip). One hour later, the rats were anesthetized with pentobarbital (65 mg/kg ip) and intravascularly perfused with 10% formalin. The colon was removed, and cryostat sections (10 µm) were mounted on chromium phosphate-gelatin coated slides. Immunohistochemistry was then performed using anti-BrdU and goat anti-donkey Cy3 secondary antibodies (Jackson Laboratories). Briefly, tissues were washed in Tris buffer containing 0.1% Triton X-100 followed by a 30-min incubation in 1 M HCl. After two washes in Tris buffer, slides were incubated with primary antibody (1:500 dilution of anti-BrdU) overnight at 4°C. Following another series of washes, slides were incubated with secondary antibody (1:1,000 dilution of donkey anti-rat) at room temperature for 4 h. Slides were examined with a fluorescence microscope and a Cy3 filter by an observer who was unaware of the treatments the rats had received. The average number of BrdU-positive cells per villus-crypt unit was determined (at least 6 randomly selected villus-crypt units were examined, and the number of BrdU-positive cells was then averaged). BrdU labeling experiments were also performed using rats that had been treated twice daily with L-NIL (as described in Bacterial translocation and colonic bacterial levels) or vehicle for 1 wk (beginning 5 wk after intracolonic administration of TNBS or the 50% ethanol vehicle; n = 6/group).
Statistical analysis. All data are expressed as means ± SE. Comparisons among groups of data were made using a one-way ANOVA followed by the Student-Neuman-Keuls Test, with the exception of the bacterial translocation incidences, for which the Fisher's Exact test was used. With all analyses, an associated probability (P value) of <5% was considered significant.
Materials. TNBS was obtained from Fluka Chimika (Buchs, Switzerland). Alcian blue 8GX, IBMX, ovalbumin, and L-NIL were obtained from Sigma Chemical (Mississauga, ON, Canada). C. difficile toxin A was purchased from Techlab (Blacksburg, VA). Safranine was obtained from Fischer Scientific (Nepean, ON, Canada). The bacterial culturing materials were obtained from Becton Dickinson (Cockeysville, MD). RMCP-II and the antibody to this protease were obtained from Moredun Animal Health (Glasgow, UK). [3H]glucosamine was obtained from ICN Biomedicals (Costa Mesa, CA). All other materials were obtained from VWR (Edmonton, AB, Canada) or Sigma Chemical.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Six weeks after TNBS administration, the histological appearance
of the colon was indistinguishable from that of naïve controls, confirming our previous observations (1). Although acute
colitis, induced either by TNBS/ethanol or ethanol alone, was
associated with a significant increase in gastrointestinal permeability
to 51Cr-EDTA, the permeability had returned to normal by 6 wk after TNBS/ethanol or ethanol administration (Fig.
1). Similarly, acute colitis was
associated with significant increases in colonic MPO activity and
colonic PGE2 synthesis, but by 6 wk after TNBS/ethanol or
ethanol administration, these changes were no longer evident (Fig. 1).
|
Effects of a prior bout of colitis on colonic secretion.
In naïve rats, toxin A from C. difficile caused
approximately a fivefold increase in fluid secretion into the colonic
loops over that observed in vehicle-treated controls (Fig.
2A). In rats in which colitis
had been induced 6 wk earlier, the fluid accumulation in colonic loops
after exposure to toxin A was significantly lower than that in
vehicle-treated controls (reduced by 53%; Fig. 2A). More
striking was the observation that the secretory response to IBMX was
completely abolished in the rats that had previously had colitis (Fig.
2B).
|
Effects of a prior bout of colitis on colonic mucus secretion.
Although a prior bout of colitis resulted in markedly diminished fluid
secretion, it did not significantly affect basal or carbachol-stimulated colonic mucus secretion (13.4 ± 2.0 vs.
11.8 ± 2.3 cpm · µg protein1 · cm
colon
1, respectively). Exposure to carbachol for 30 min
caused an ~20-fold increase in [3H]glucosamine-labeled
glycoprotein release in both naïve and postcolitis rats
(202.4 ± 44.3 vs. 238.4 ± 45.6 cpm · µg
protein
1 · cm colon
1, respectively).
Effects of a prior bout of enteritis on colonic secretion.
The effects of antigen (ovalbumin) on chloride secretion by the colon
were examined in vitro in postcolitis rats vs. naïve controls.
Addition of the antigen to the serosal side of the colonic tissue from
naïve, sensitized rats resulted in a 10-fold increase in
Isc, which is generated primarily by active
chloride secretion into the lumen (Fig.
3). When the same experiments were
performed in naïve rats that had not been sensitized to the
antigen, no secretory response was observed. Antigen challenge of
colonic tissue from sensitized, postcolitis rats did not elicit a
secretory response (Fig. 3). Indeed, the response to antigen was no
different from that in postcolitis rats that had not been sensitized to the antigen. The absence of a secretory response to antigen in the
sensitized postcolitis rats was not due to a failure of the antigen to
cause mucosal mast cell degranulation, since we observed a significant
increase (3-fold) in the luminal levels of the mucosal mast cell
protease RMCP-II in these rats. A doubling of RMCP-II concentrations in
the luminal side of the Ussing chamber was noted in naïve,
sensitized rats following challenge with the antigen. Moreover, all
rats used in this study as "sensitized" were confirmed to be
sensitized by a positive PCA test.
|
Effects of a prior bout of enteritis on colonic mucus secretion.
Colonic tissue that was fixed 52 days after N. brasiliensis infection did not exhibit any histological
evidence of inflammation. Toxin A caused a significant increase
(2.8-fold) in fluid accumulation in the colon of control rats (Fig.
4). In colonic loops from rats previously
infected with N. brasiliensis, toxin A caused
significantly less fluid accumulation than in controls (33%
reduction). There was no significant difference in the amount of fluid
recovered from toxin A-treated vs. vehicle-treated loops in rats
previously infected with N. brasiliensis.
|
Effects of iNOS inhibition on colonic secretion.
Treatment with L-NIL 10 min before toxin A administration
did not have any effect on colonic fluid accumulation in naïve rats (Fig. 5). Similarly,
L-NIL pretreatment did not affect colonic secretion in rats
treated with TNBS 6 wk earlier; that is, the volume of fluid recovered
from toxin A-treated colonic loops in postcolitis rats remained
significantly reduced compared with the volume recovered from controls.
In contrast, in IBMX-stimulated colonic loops, the volume of fluid
recovered in postcolitis rats pretreated with L-NIL was not
different from the volume of fluid recovered from naïve rats
(i.e., L-NIL partially reversed the hyposecretion; Fig. 5).
|
Effects of TTX.
Pretreatment with TTX did not significantly affect the
hyporesponsiveness to IBMX in rats 6 wk after induction of colitis (Fig. 6). TTX also had no significant
effect on the secretory response to IBMX in control rats.
|
Colonic bacterial levels and bacterial translocation: effects of a
prior bout of colitis.
Despite the normal macroscopic and histological appearance of the
colon, there were marked changes in bacterial colonization of the colon
6 wk after induction of colitis. We observed a 16-fold increase in the
number of aerobic bacteria in the colon (tissue + lumen) of
postcolitis rats compared with controls (Table
1). However, there was no difference in
the number of aerobic bacteria between control and postcolitis rats
when only tissue levels (adherent + invasive) were examined
(4.4 ± 0.6 vs. 5.0 ± 0.5 log10 CFU/g, respectively). Total gram-negative bacterial levels in the colon (4.4 ± 0.9 vs. 4.2 ± 0.9 log10 CFU/g) and total
anaerobes (7.1 ± 0.5 vs. 7.4 ± 0.5 log10 CFU/g)
were also not different between control and postcolitis rats,
respectively. As shown in Table 1, aerobic bacterial translocation to
either the mesenteric lymph nodes or spleen was observed in 77% of the
rats examined 6 wk after administration of TNBS, significantly greater
(P < 0.0005) than the 23% incidence in naïve
rats. In terms of the types of bacterial colonization in the
postcolitis rats vs. naïve controls, there were few major
differences. Escherichia coli and Enterococci species were the predominant bacteria in both naïve and
postcolitis rats.
|
Colonic bacterial levels and bacterial translocation: effects of a
prior bout of enteritis.
In Sprague-Dawley rats that had been infected with N. brasiliensis 52 days earlier, the colonic aerobic bacterial
numbers were 10-fold higher (P < 0.05) than in
naïve controls (Table 2). Unlike
the case in the postcolitis rats, there was also a significant increase
(25-fold) in the numbers of gram-negative bacteria in the colons of the
postenteritis rats compared with controls (P < 0.01).
The incidence of bacterial translocation in rats that previously had
enteritis was 54%, significantly greater (P < 0.05)
than the 23% incidence in naïve controls (Table 2).
|
Colonic epithelial proliferation. The average number of BrdU-positive cells per crypt-villus unit in untreated control rats was 19.2 ± 1.9 (n = 13), and that in rats treated intracolonically with 50% ethanol 6 wk earlier was 20.7 ± 2.0 (n = 6). Rats examined 6 wk after intracolonic administration of TNBS exhibited a significant increase in BrdU labeling (35.4 ± 4.0; n = 6; P < 0.05), whereas in rats that were treated 6 wk earlier with the ethanol vehicle, the numbers of BrdU-positive cells per crypt-villus unit were similar to those in untreated controls (20.7 ± 2.0; n = 6). Treatment with L-NIL for 1 wk did not significantly affect the rate of epithelial proliferation in postcolitis rats (38.0 ± 4.1 positive cells per crypt-villus unit vs. 34.5 ± 2.7 in vehicle-treated controls; n = 6-10 per group).
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The epithelium of the gastrointestinal tract forms an important barrier, limiting the entry of luminal microbes and toxins into the lamina propria. Epithelial secretion of electrolytes, water, and mucus may also participate in this aspect of host defense. For example, epithelial secretion has been suggested to play a role in clearing antigenic material from the intestinal lumen, diluting toxins, and limiting bacterial colonization (10). During inflammatory reactions, epithelial secretion may be altered as a result of the release of soluble mediators such as prostaglandins, NO, and various cytokines. However, following the resolution of inflammation, epithelial dysfunction can persist for prolonged periods of time. We have previously demonstrated that epithelial dysfunction in vitro persists for at least 12 wk after the episode of inflammation (TNBS-induced colitis), but this dysfunction was not seen in rats given only the ethanol vehicle (1). In the present study, we have extended this observation by demonstrating that colonic epithelial hyporesponsiveness can be observed in vivo for at least 6 wk after induction of colitis and also after resolution of small intestinal inflammation. The secretory dysfunction was a generalized effect, rather than being specific to a single stimulus. Thus the hyporesponsiveness was observed in vivo with two secretagogues that have distinct mechanisms of action (C. difficile toxin A and IBMX), and secretory dysfunction in vitro was demonstrated in a model of antigen-induced epithelial chloride secretion. Moreover, the rats that had previously been subjected to colitis or enteritis also exhibited significant increases in bacterial colonization of the colon, consistent with the notion that colonic epithelial secretion normally reduces bacterial colonization. The impairment of colonic secretion may also have contributed to the significant increase in bacterial translocation in the rats that previously had experienced a bout of colitis or enteritis. Interestingly, the tripling of the rate of bacterial translocation in postcolitis rats occurred despite the gastrointestinal epithelial permeability to a small molecular weight probe (EDTA) not being significantly different from that in normal rats. The fact that we have observed a marked increase in bacterial translocation in the absence of any detectable change in permeability suggests that caution should be exercised in drawing conclusions from studies that use permeability probes as a sole index of "barrier function."
The results of the present study suggest a key role for iNOS-derived NO in the mechanism underlying the bacterial translocation and, to a lesser extent, epithelial hyporesponsiveness following a bout of colitis. The reversal of the postcolitis bacterial translocation by treatment with a selective iNOS inhibitor is consistent with a number of previous studies that suggested that iNOS-derived NO played a role in endotoxin- or ischemia-reperfusion-induced bacterial translocation in the intestine (11, 24, 46), although a molecular mechanism of action has not been identified. In previous in vitro studies in which epithelial hyporesponsiveness persisted for >12 wk after a bout of colitis, inhibition of iNOS was found to normalize the responsiveness of the colonic epithelium to electrical field stimulation and IBMX but not to carbachol (1). On the basis of these data, we proposed that NO might contribute to the hyporesponsiveness by affecting cAMP-mediated (such as that activated by IBMX) but not calcium-mediated (such as that activated by carbachol) pathways of secretion. Recent studies by Freeman et al. (14) suggest that NO-mediated enterocyte hyporesponsiveness may be due to effects mediated at the level of adenylate cyclase. Our in vivo findings in the present study demonstrate that L-NIL treatment only partially reversed the epithelial hyporesponsiveness to IBMX and had no effect on C. difficile toxin A-stimulated secretion. C. difficile toxin A is believed to elicit its secretagogue effects through calcium-dependent pathways (19, 40), and previously it was demonstrated that an inhibitor of iNOS (aminoguanidine) had no effect on the secretory response to this toxin (41). C. difficile toxin A has also been shown to elicit epithelial toxicity. Consequently, it was possible that the difference in fluid accumulation levels observed between naïve and postcolitis rats could have been due to increased susceptibility to toxin A-induced damage in the latter group. However, cellular toxicity (as determined by lactate dehydrogenase release) in toxin A-treated vs. vehicle-treated colonic loops from naïve and postcolitis rats was not significantly different.
As mentioned above, acute administration of L-NIL (iNOS inhibitor) resulted in a partial reversal of the hyporesponsiveness to stimulation with IBMX. This indicates that the epithelial dysfunction was not attributable simply to an absence of the cellular apparatus for active chloride section (e.g., loss of expression of the chloride transporter). The results of the present study are consistent with the hypothesis that the defect lies at the level of the enterocyte rather than in cells in the lamina propria that can influence epithelial chloride secretion (e.g., nerves, mast cells). For example, in both the present study and in our previous in vitro study, we observed that the hyporesponsiveness was evident with a number of different secretagogues that act through different pathways. Moreover, in the present study we observed a complete absence of an epithelial secretory response to antigen in sensitized, postcolitis rats despite the fact that the antigen still caused mucosal mast cell degranulation. Finally, the observation that TTX did not reverse the hyporesponsiveness to IBMX suggests that changes produced by a prior bout of colitis are not attributable to alterations in the neural elements that regulate epithelial secretion.
In addition to the long-term changes in epithelial secretory function and bacterial translocation after a bout of colitis, we observed a significant increase in bacterial colonization and in the proliferation of the colonic epithelium. Unlike the bacterial translocation and secretory dysfunction (at least in response to IBMX), bacterial colonization levels and rates of colonocyte proliferation were not significantly affected by treatment with L-NIL. If the increase in bacterial colonization occurred as a consequence of impaired colonic secretion, then the lack of effect of treatment with L-NIL on bacterial numbers is not surprising. As discussed above, only a portion of the hyporesponsiveness appeared to be NO dependent. Further studies are needed to more fully comprehend the mechanisms responsible for colonic hyposecretion after colitis, which will then permit studies to determine the extent to which the changes in bacterial translocation (and possibly proliferation) are a consequence of the impaired secretory responsiveness.
The findings of this study may have important implications for understanding the pathogenesis of inflammatory bowel disease and irritable bowel syndrome. Intestinal infection has been suggested to be one of the possible triggers of inflammatory bowel disease (13). Several studies have reported that in a significant percentage of patients with irritable bowel syndrome, the symptoms can be traced to a bout of intestinal infection (17, 27, 32, 42). The present study has demonstrated that a bout of intestinal inflammation can cause long-lasting changes in epithelial function (secretion and proliferation) that could contribute to an increased propensity for infection and/or inflammation. There is also evidence of long-term changes in nerve and muscle function after a bout of colitis in humans and in animal models (16, 21, 47, 50). In addition, myenteric nerve function has been shown to be altered not only at the site of the inflammatory reaction but also at more distant, noninflamed sites (20, 31). These changes, along with the hyporesponsiveness of the epithelium, could contribute not only to reduced mucosal defense but also to the generation of symptoms (diarrhea, pain) in patients with inflammatory bowel disease or irritable bowel syndrome.
![]() |
ACKNOWLEDGEMENTS |
---|
This work was supported by grants from the Medical Research Council of Canada (MRC) to J. L. Wallace and from the Crohn's and Colitis Foundation of Canada to W. K. MacNaughton. S. Asfaha is supported by an MRC Studentship. W. K. MacNaughton is supported by an Alberta Heritage Foundation for Medical Research (AHFMR) Scholar award. J. L. Wallace is supported by an MRC Senior Scientist award and an AHFMR Senior Scientist award.
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: J. L. Wallace, Dept. of Pharmacology and Therapeutics, Univ. of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada (E-mail: wallacej{at}ucalgary.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 28 September 2000; accepted in final form 16 May 2001.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Asfaha, S,
Bell CJ,
Wallace JL,
and
MacNaughton WK.
Prolonged colonic epithelial hyporesponsiveness after colitis: role of inducible nitric oxide synthase.
Am J Physiol Gastrointest Liver Physiol
276:
G703-G710,
1999
2.
Befus, AD,
and
Bienenstock J.
Immunologically mediated intestinal mastocytosis in Nippostrongylus brasiliensis-infected rats.
Immunology
38:
95-101,
1979[ISI][Medline].
3.
Bell, CJ,
Gall DG,
and
Wallace JL.
Disruption of colonic electrolyte transport in experimental colitis.
Am J Physiol Gastrointest Liver Physiol
268:
G622-G630,
1995
4.
Belley, A,
and
Chadee K.
Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor.
Gastroenterology
117:
1352-1362,
1999[ISI][Medline].
5.
Bermeyer, HU,
and
Bernt E.
Lactate dehydrogenase: UV-assay with pyruvate and NADH.
In: Methods of Enzymatic Analysis, , edited by Bermeyer HU.. New York: Academic, 1974, vol. 2, p. 574-579.
6.
Cartwright, CA,
McRoberts JA,
Mandel KG,
and
Dharmsathaphorn K.
Synergistic action of cyclic adenosine monophosphate- and calcium-mediated chloride secretion in a colonic epithelial cell line.
J Clin Invest
76:
1837-1842,
1985[ISI][Medline].
7.
Castagliuolo, I,
LaMont JT,
Letourneau R,
Kelly C,
O'Keane JC,
Jaffer A,
Theoharides TC,
and
Pothoulakis C.
Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum.
Gastroenterology
107:
657-665,
1994[ISI][Medline].
8.
Chadee, K,
Keller K,
Forstner J,
Innes DJ,
and
Ravdin JI.
Mucin and nonmucin secretagogue activity of Entamoeba histolytica and cholera toxin in rat colon.
Gastroenterology
100:
986-997,
1991[ISI][Medline].
9.
Chang, EB,
Musch MW,
and
Mayer L.
Interleukins 1 and 3 stimulate anion secretion in chicken intestine.
Gastroenterology
98:
1518-1524,
1990[ISI][Medline].
10.
Chang, EB,
and
Rao MC.
Intestinal water and electrolyte transport: mechanisms of physiological and adaptive responses.
In: Physiology of the Gastrointestinal Tract (3rd ed.), edited by Johnson LR.. New York: Raven, 1994, p. 2027-2081.
11.
Dickinson, E,
Tuncer R,
Nadler E,
Boyle P,
Alber S,
Watkins S,
and
Ford H.
NOX, a novel nitric oxide scavenger, reduces bacterial translocation in rats after endotoxin challenge.
Am J Physiol Gastrointest Liver Physiol
277:
G1281-G1287,
1999
12.
Evangelista, S,
Maggi M,
and
Renzetti AR.
Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats.
Neuropeptides
30:
425-428,
1996[ISI][Medline].
13.
Fiocchi, C.
Inflammatory bowel disease: etiology and pathogenesis.
Gastroenterology
115:
182-205,
1998[ISI][Medline].
14.
Freeman, SL,
Davison G,
and
MacNaughton WK.
The nitric oxide-dependent component of radiation-induced epithelial hyporesponsiveness occurs through inhibition of adenylate cyclase activity (Abstract).
Can J Gastroenterol
15, SupplA:
17A,
2001.
15.
Goldhill, JM,
Burakoff R,
Donovan V,
Rose K,
and
Percy WH.
Defective modulation of colonic secretomotor neurons in a rabbit model of colitis.
Am J Physiol Gastrointest Liver Physiol
264:
G671-G677,
1993
16.
Grossi, L,
McHugh K,
and
Collins SM.
On the specificity of altered muscle function in experimental colitis in rats.
Gastroenterology
104:
1049-1056,
1993[ISI][Medline].
17.
Gwee, KA,
Graham JC,
McKendrick MW,
Collins SM,
Marshall JS,
Walters SJ,
and
Read NW.
Psychometric scores and persistence of irritable bowel after infectious diarrhoea.
Lancet
347:
150-153,
1996[ISI][Medline].
18.
Hogaboam, CM,
Befus AD,
and
Wallace JL.
Intestinal platelet-activating factor synthesis during Nippostrongylus brasiliensis infection in the rat.
J Lipid Mediators
4:
211-224,
1991[ISI][Medline].
19.
Hughes, S,
Warhurst G,
Turnberg LA,
Higgs NB,
Giugliano LG,
and
Drasar BS.
Clostridium difficile toxin-induced intestinal secretion in rabbit ileum in vitro.
Gut
24:
94-98,
1983[Abstract].
20.
Jacobson, K,
McHugh K,
and
Collins SM.
Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat.
Gastroenterology
109:
718-722,
1995[ISI][Medline].
21.
Jacobson, K,
McHugh K,
and
Collins SM.
The mechanism of altered neural function in a rat model of acute colitis.
Gastroenterology
112:
156-162,
1997[ISI][Medline].
22.
Kachur, JF,
Keshavarzian A,
Sundaresan R,
Doria M,
Walsh R,
de las Alas MM,
and
Gaginella TS.
Colitis reduces short-circuit current response to inflammatory mediators in rat colonic mucosa.
Inflammation
19:
245-259,
1995[ISI][Medline].
23.
Katayama, M,
Xu D,
Specian RD,
and
Deitch EA.
Role of bacterial adherence and the mucus barrier on bacterial translocation: effects of protein malnutrition and endotoxin in rats.
Ann Surg
225:
317-326,
1997[ISI][Medline].
24.
Kavuklu, B,
Agalar C,
Guc MO,
and
Sayek I.
Evidence that aminoguanidine inhibits endotoxin-induced bacterial translocation.
Br J Surg
85:
1103-1106,
1998[ISI][Medline].
25.
Keenan, CM,
and
Rangachari PK.
Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon.
Am J Physiol Gastrointest Liver Physiol
260:
G481-G488,
1991
26.
Kone, BC,
and
Higham S.
Nitric oxide inhibits transcription of the Na+-K+-ATPase 1-subunit gene in an MTAL cell line.
Am J Physiol Renal Physiol
276:
F614-F621,
1999
27.
LaMont, JT,
and
Trnka YM.
Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease.
Lancet
1:
381-383,
1980[ISI][Medline].
28.
MacNaughton, WK.
Nitric oxide-donating compounds stimulate electrolyte transport in the guinea pig intestine in vitro.
Life Sci
53:
585-593,
1993[ISI][Medline].
29.
MacNaughton, WK,
Lowe SS,
and
Cushing K.
Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis.
Am J Physiol Gastrointest Liver Physiol
275:
G1353-G1360,
1998
30.
Madara, JL,
and
Stafford J.
Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.
J Clin Invest
83:
724-727,
1989[ISI][Medline].
31.
Marzio, L,
Blennerhassett P,
Chiverton S,
Vermillion DL,
Langer J,
and
Collins SM.
Altered smooth muscle function in worm-free gut regions of Trichinella-infected rats.
Am J Physiol Gastrointest Liver Physiol
259:
G306-G313,
1990
32.
McKendrick, MW,
and
Read NW.
Irritable bowel syndromepost salmonella infection.
J Infect
29:
1-3,
1994[ISI][Medline].
33.
Mitchell, TJ,
Ketley JM,
Burdon DW,
Candy DC,
and
Stephen J.
The effects of Clostridium difficile crude toxins and purified toxin A on stripped rabbit ileal mucosa in Ussing chambers.
J Med Microbiol
23:
199-204,
1987[Abstract].
34.
Moore, R,
Pothoulakis C,
LaMont JT,
Carlson S,
and
Madara JL.
C. difficile toxin A increases intestinal permeability and induces Cl secretion.
Am J Physiol Gastrointest Liver Physiol
259:
G165-G172,
1990
35.
Morris, GP,
Beck PL,
Herridge MS,
Depew WT,
Szewczuk MR,
and
Wallace JL.
Hapten-induced model of chronic inflammation and ulceration in the rat colon.
Gastroenterology
96:
795-803,
1989[ISI][Medline].
36.
Ogilvie, BM,
Askenase PW,
and
Rose ME.
Basophils and eosinophils in three strains of rats and in athymic (nude) rats following infection with the nematodes Nippostrongylus brasiliensis or Trichinella spiralis.
Immunology
39:
385-389,
1980[ISI][Medline].
37.
Ogilvie, BM,
Mackenzie CD,
and
Love RJ.
Lymphocytes and eosinophils in the immune response of rats to initial and subsequent infections with Nippostrongylus brasiliensis.
Am J Trop Med Hyg
26:
61-67,
1977[ISI][Medline].
38.
Ovary, Z.
Passive cutaneous anaphylaxis.
In: CIOMS Symposium, edited by Ackrody JF.. Oxford, UK: Blackwell, 2000, p. 259-270.
39.
Perdue, MH,
Masson S,
Wershil BK,
and
Galli SJ.
Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/Wv mice by bone marrow transplantation.
J Clin Invest
87:
687-693,
1991[ISI][Medline].
40.
Pothoulakis, C,
Sullivan R,
Melnick DA,
Triadafilopoulos G,
Gadenne AS,
Meshulam T,
and
LaMont JT.
Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.
J Clin Invest
81:
1741-1745,
1988[ISI][Medline].
41.
Qiu, B,
Pothoulakis C,
Castagliuolo I,
Nikulasson Z,
and
LaMont JT.
Nitric oxide inhibits rat intestinal secretion by Clostridium difficile toxin A but not Vibrio cholerae enterotoxin.
Gastroenterology
111:
409-418,
1996[ISI][Medline].
42.
Rodriguez, LA,
and
Ruigomez A.
Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study.
Br Med J
318:
565-566,
1999
43.
Schirgi-Degen, A,
and
Beubler E.
Significance of nitric oxide in the stimulation of intestinal fluid absorption in the rat jejunum in vivo.
Br J Pharmacol
114:
13-18,
1995[Abstract].
44.
Schwartz, D,
Mendonca M,
Schwartz I,
Xia Y,
Satriano J,
Wilson CB,
and
Blantz RC.
Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats.
J Clin Invest
100:
439-448,
1997
45.
Scudamore, CL,
Thornton EM,
McMillan L,
Newlands GF,
and
Miller HR.
Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum.
J Exp Med
182:
1871-1881,
1995[Abstract].
46.
Suzuki, Y,
Deitch EA,
Mishima S,
Lu Q,
and
Xu D.
Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury.
Crit Care Med
28:
3692-3696,
2000[ISI][Medline].
47.
Swain, MG,
Blennerhassett PA,
and
Collins SM.
Impaired sympathetic nerve function in the inflamed rat intestine.
Gastroenterology
100:
675-682,
1991[ISI][Medline].
48.
Tamai, H,
and
Gaginella TS.
Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon.
Free Radic Res Commun
19:
229-239,
1993[ISI][Medline].
49.
Traynor, TR,
Brown DR,
and
O'Grady SM.
Effects of inflammatory mediators on electrolyte transport across the porcine distal colon epithelium.
J Pharmacol Exp Ther
264:
61-66,
1993[Abstract].
50.
Vermillion, DL,
Huizinga JD,
Riddell RH,
and
Collins SM.
Altered small intestinal smooth muscle function in Crohn's disease.
Gastroenterology
104:
1692-1699,
1993[ISI][Medline].
51.
Wang, L,
Stanisz AM,
Wershil BK,
Galli SJ,
and
Perdue MH.
Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells.
Am J Physiol Gastrointest Liver Physiol
269:
G85-G92,
1995
52.
Wang, S,
Yan L,
Wesley RA,
and
Danner RL.
Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP.
J Biol Chem
272:
5959-5965,
1997
53.
Wang, YZ,
Cooke HJ,
Su HC,
and
Fertel R.
Histamine augments colonic secretion in guinea pig distal colon.
Am J Physiol Gastrointest Liver Physiol
258:
G432-G439,
1990
54.
Wardle, TD,
Hall L,
and
Turnberg LA.
Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion.
Gut
38:
355-361,
1996[Abstract].
55.
Wilson, KT,
Vaandrager AB,
De Vente J,
Musch MW,
De Jonge HR,
and
Chang EB.
Production and localization of cGMP and PGE2 in nitroprusside-stimulated rat colonic ion transport.
Am J Physiol Cell Physiol
270:
C832-C840,
1996
56.
Zund, G,
Madara JL,
Dzus AL,
Awtrey CS,
and
Colgan SP.
Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion.
J Biol Chem
271:
7460-7464,
1996